These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [New medical therapy of neuroendocrine gastrointestinal tumors]. Eriksson B; Janson ET; Skogseid B; Oberg K Lakartidningen; 1990 Aug; 87(35):2668-72. PubMed ID: 2214974 [No Abstract] [Full Text] [Related]
7. [Antineoplastic chemotherapy of digestive tumors]. Espinosa Arranz E; Ordóñez Gallego A; González Barón M Med Clin (Barc); 1991 Mar; 96(12):471-4. PubMed ID: 2056788 [No Abstract] [Full Text] [Related]
8. The use of chemotherapy in the management of neuroendocrine tumors. Oberg K Endocrinol Metab Clin North Am; 1993 Dec; 22(4):941-52. PubMed ID: 8125079 [TBL] [Abstract][Full Text] [Related]
9. [An new generation of antineoplastic agents--targeted therapy in gastrointestinal tumors]. Lang A; Graeven U Zentralbl Chir; 2009 Jun; 134(3):189-92. PubMed ID: 19544236 [No Abstract] [Full Text] [Related]
11. Molecular target therapy for gastroenteropancreatic endocrine tumours: biological rationale and clinical perspectives. Capurso G; Fazio N; Festa S; Panzuto F; De Braud F; Delle Fave G Crit Rev Oncol Hematol; 2009 Nov; 72(2):110-24. PubMed ID: 19249226 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in the nonsurgical treatment of upper gastrointestinal tract tumors. Thomas AL; Steward WP Expert Rev Anticancer Ther; 2001 Aug; 1(2):258-68. PubMed ID: 12113031 [TBL] [Abstract][Full Text] [Related]
13. The role of somatostatin analogs in the management of carcinoid tumors. Tomassetti P; Migliori M; Campana D; Brocchi E; Piscitelli L; Tomassetti V; Corinaldesi R J Endocrinol Invest; 2003; 26(8 Suppl):79-81. PubMed ID: 15233219 [No Abstract] [Full Text] [Related]
14. Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors. Shah MH; Young D; Kindler HL; Webb I; Kleiber B; Wright J; Grever M Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6111-8. PubMed ID: 15447997 [TBL] [Abstract][Full Text] [Related]
15. [Therapeutic advances in digestive oncology. III. Chemotherapy of digestive system cancers]. Zeitoun P; Martin F; Nasca S Med Chir Dig; 1979; 8(7):655-60. PubMed ID: 94142 [No Abstract] [Full Text] [Related]
16. Gastrointestinal endocrine tumors: diagnosis and management. Role of somatostatin analogue SMS 201-995. July 4-6, 1986, Vancouver, British Columbia. Proceedings. Am J Med; 1987 May; 82(5B):1-99. PubMed ID: 2884875 [No Abstract] [Full Text] [Related]
17. Chemotherapy of endocrine malignancies: a review. Kvols LK; Buck M Semin Oncol; 1987 Sep; 14(3):343-53. PubMed ID: 2820064 [No Abstract] [Full Text] [Related]
19. [Carcinoid tumors]. Tóth M; Prónai L; Németh AM; Tulassay Z Orv Hetil; 2002 May; 143(19 Suppl):1087-92. PubMed ID: 12063867 [TBL] [Abstract][Full Text] [Related]
20. [Is it possible to predict the response of digestive cancers to chemotherapy?]. Ballet F Gastroenterol Clin Biol; 1983 Apr; 7(4):370-3. PubMed ID: 6873548 [No Abstract] [Full Text] [Related] [Next] [New Search]